MADDER

OTHER NAME(S):

Bengal Madder, Dyer's Madder, Fäberröte, Garança, Garance, Garance des Teinturiers, Granza, Indian Madder, Krapp, Robbia, Rouge des Teinturiers, Rubia, Rubia de Tintas, Rubia tinctorum, Rubiae Tinctorum Radix.<br/><br/>

Overview

Overview Information

Madder is a plant. The root is used to make medicine.

Despite serious safety concerns, people take madder by mouth for preventing and dissolving kidney stones, as well as and for treating general menstrual disorders, and urinary tract disorders, blood disorders, bruises, jaundice, paralysis, spleen disorders, and sciatica. It is also used to promote urination, as an aphrodiasiac, and as a tonic.

Madder is also applied to the skin for certain skin conditions and to promote wound healing.

How does it work?

Some chemicals in madder might help prevent kidney stones. The chemical in madder known as alizarin might block a protein that is needed by the HIV virus to replicate.

Uses

Uses & Effectiveness?

Insufficient Evidence for

  • Kidney stones.
  • Menstrual problems.
  • Urinary problems.
  • Blood disorders.
  • Bruises.
  • Jaundice.
  • Paralysis.
  • Spleen disorders.
  • Pain along the sciatic nerve (sciatica).
  • Wound healing.
  • Other conditions.
More evidence is needed to rate the effectiveness of madder for these uses.

Side Effects

Side Effects & Safety

Madder is considered LIKELY UNSAFE when taken by mouth. The chemicals in madder may cause cancer. Madder can also cause urine, saliva, perspiration, tears, and breast milk to turn red in color.

Special Precautions & Warnings:

Pregnancy and breast-feeding: It's UNSAFE to take madder by mouth if you are pregnant. It might start your menstrual period and that could cause a miscarriage. Madder might also cause birth defects.

It's also UNSAFE to use madder if you are breast-feeding. It might harm the nursing baby, and it might turn breast milk red.

Interactions

Interactions?

We currently have no information for MADDER Interactions.

Dosing

Dosing

The appropriate dose of madder depends on several factors such as the user's age, health, and several other conditions. At this time there is not enough scientific information to determine an appropriate range of doses for madder. Keep in mind that natural products are not always necessarily safe and dosages can be important. Be sure to follow relevant directions on product labels and consult your pharmacist or physician or other healthcare professional before using.

View References

REFERENCES:

  • Blomeke B, Poginsky B, Schmutte C, Marquardt H, Westendorf J. Formation of genotoxic metabolites from anthraquinone glycosides, present in Rubia tinctorum L. Mutat Res 1992;265(2):263-272.View abstract.
  • Boldizsár I, Szucs Z, Füzfai Z, Molnár-Perl I. Identification and quantification of the constituents of madder root by gas chromatography and high-performance liquid chromatography. J Chromatogr A 2006;1133(1-2):259-74. View abstract.
  • Brinkworth RI, Fairlie DP. Hydroxyquinones are competitive non-peptide inhibitors of HIV-1 proteinase. Biochim Biophys Acta 1995;1253(1):5-8.View abstract.
  • Castelain M, Ducombs G. Contact dermatitis from madder. Contact Dermatitis 1988;19(3):228-229. View abstract.
  • Fetrow CW, Avila JR. Professional's Handbook of Complementary & Alternative Medicines. 1st ed. Springhouse, PA: Springhouse Corp., 1999.
  • Ino N, Tanaka T, Okumura A, et al. Acute and subacute toxicity tests of madder root, natural colorant extracted from madder (Rubia tinctorum), in (C57BL/6 X C3H)F1 mice. Toxicol Ind Health 1995;11(4):449-458. View abstract.
  • Kawasaki Y, Goda Y, Yoshihira K. The mutagenic constituents of Rubia tinctorum. Chem Pharm Bull (Tokyo) 1992;40(6):1504-1509. View abstract.
  • Lorenz D, Lucker PW, Krumbiegel G, Mennicke WH, Wetzelsberger N. Pharmacokinetic studies of alizarin in man. Methods Find Exp Clin Pharmacol 1985;7(12):637-643.View abstract.
  • Myers HM. Alizarin and tetracycline binding by bone mineral. Am J Phys Anthropol 1968;29(2):179-182. View abstract.
  • Norton SA. Useful plants of dermatology. IV. Alizarin red and madder. J Am Acad Dermatol 1998;39(3):484-485. View abstract.
  • Poginsky B, Westendorf J, Blomeke B, et al. Evaluation of DNA-binding activity of hydroxyanthraquinones occurring in Rubia tinctorum L. Carcinogenesis 1991;12(7):1265-1271. View abstract.
  • Puchtler H, Meloan SN, Terry MS. On the history and mechanism of alizarin and alizarin red S stains for calcium. J Histochem Cytochem 1969;17(2):110-124. View abstract.
  • Weiner MA, Weiner JA. Herbs that heal: prescription for herbal healing. Mill Valley, CA:Quantum Books, 1999.
  • Westendorf J, Pfau W, Schulte A. Carcinogenicity and DNA adduct formation observed in ACI rats after long-term treatment with madder root, Rubia tinctorum L. Carcinogenesis 1998;19:2163-8. View abstract.
  • Westendorf J, Poginsky B, Marquardt H, Groth G, Marquardt H. The genotoxicity of lucidin, a natural component of Rubia tinctorum L., and lucidinethylether, a component of ethanolic Rubia extracts. Cell Biol Toxicol 1988;4(2):225-239.View abstract.

More Resources for MADDER

CONDITIONS OF USE AND IMPORTANT INFORMATION: This information is meant to supplement, not replace advice from your doctor or healthcare provider and is not meant to cover all possible uses, precautions, interactions or adverse effects. This information may not fit your specific health circumstances. Never delay or disregard seeking professional medical advice from your doctor or other qualified health care provider because of something you have read on WebMD. You should always speak with your doctor or health care professional before you start, stop, or change any prescribed part of your health care plan or treatment and to determine what course of therapy is right for you.

This copyrighted material is provided by Natural Medicines Comprehensive Database Consumer Version. Information from this source is evidence-based and objective, and without commercial influence. For professional medical information on natural medicines, see Natural Medicines Comprehensive Database Professional Version.
© Therapeutic Research Faculty 2018.